Efficacy of two times four versus continuous eight cycles of paclitaxel/bevacizumab as first-line chemotherapy in metastatic breast cancer: The Stop&Go study of the Dutch Breast Cancer Research Group (BOOG)

Verfasser: Claessens, A.
Bos, M.
de Groot, S.
van Leeuwen-Stok, E.
Lopez-Yurda, M.
Honkoop, A.
de Graaf, H.
van Druten, E.
van Warmerdam, L.
van der Sangen, M.
Tjan-Heijnen, V.
Erdkamp, F.
Dokumenttyp: Artikel
Erscheinungsdatum: 2017
Reihe/Periodikum: Annals of Oncology ; volume 28, page v78-v79 ; ISSN 0923-7534
Verlag/Hrsg.: Elsevier BV
Schlagwörter: Oncology / Hematology
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26636387
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://dx.doi.org/10.1093/annonc/mdx365.009